Trihydroxy polyunsaturated eicosanoid
The invention features methods for the preparation of naturally occurring trihydroxy polyunsaturated eicosanoids and their structural analogs. The invention further provides new derivatives and analogs of trihydroxy polyunsaturated eicosanoids that can be prepared according to these methods. The invention also provides compositions and methods using trihydroxy polyunsaturated eicosanoid derivatives for the prevention, amelioration and treatment of a variety of diseases or conditions associated with inflammation or inflammatory response, autoimmune diseases, rheumatoid arthritis, cardiovascular diseases, or abnormal cell proliferation or cancer.
1. A method of ameliorating or treating a disease or condition associated with inflammation, autoimmune disease, or rheumatoid arthritis, the method comprising administering to a subject an effective amount of a compound having a structure of general formula 46:
wherein:
A is hydroxy, alkoxy, aryloxy, amino, alkylamino, dialkylamino, or —OM, where M is a cation selected from ammonium, tetra-alkyl ammonium, Na, K, Mg, and Zn;
R a and R b are independently selected from hydrogen, alkyl, aryl, heteroaryl, acyl, silyl, alkoxyacyl and aminoacyl;
R 2 is hydrogen, alkyl, perfluoroalkyl, aryl or heteroaryl;
R 5 is selected from i)-iv) as follows:
i) CH 2 CH(R 6 )CH 2 , where R 6 is hydrogen, alkyl, perfluoroalkyl, aryl, heteroaryl, fluoro, hydroxy or alkoxy;
ii) CH 2 C(R 6 R 7 )CH 2 , where R 6 and R 7 are each independently alkyl, perfluoroalkyl, aryl, or fluoro, or R 6 and R 7 are connected together to form a carbocyclic or heterocyclic ring;
iii) CH 2 OCH 2 , CH 2 C(O)CH 2 , or CH 2 CH 2 ; and
iv) a carbocyclic, heterocyclic, aryl or heteroaryl ring; and
R 8 and R 9 are independently selected from hydrogen, alkyl, perfluoroalkyl, alkoxy, aryl and heteroaryl, or R 8 and R 9 are connected together to form a carbocyclic or heterocyclic ring.
2. The method of claim 1 , wherein R a and R b are independently selected from hydrogen, acyl, alkoxyacyl and aminoacyl.
3. The method of claim 1 , wherein the compound has a structure of general formula 44,
4. The method of claim 3 , wherein R a and R b are independently selected from hydrogen, acyl, alkoxyacyl and aminoacyl.
5. The method of claim 3 for ameliorating or treating a disease or condition associated with inflammation.
6. The method of claim 3 , wherein the compound has a structure of general formula 29,
7. The method of claim 6 , wherein R a and R b are independently selected from hydrogen, acyl, alkoxyacyl and aminoacyl.
8. The method of claim 6 for ameliorating or treating a disease or condition associated with inflammation.
9. A method of ameliorating or treating a disease or condition associated with inflammation, autoimmune disease, or rheumatoid arthritis, the method comprising administering to a subject an effective amount of a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound having a structure of general formula 46:
wherein:
A is hydroxy, alkoxy, aryloxy, amino, alkylamino, dialkylamino, or —OM, where M is a cation selected from ammonium, tetra-alkyl ammonium, Na, K, Mg, and Zn;
R a and R b are independently selected from hydrogen, alkyl, aryl, heteroaryl, acyl, silyl, alkoxyacyl and aminoacyl;
R 2 is hydrogen, alkyl, perfluoroalkyl, aryl or heteroaryl;
R 5 is selected from i)-iv) as follows:
i) CH 2 CH(R 6 )CH 2 , where R 6 is hydrogen, alkyl, perfluoroalkyl, aryl, heteroaryl, fluoro, hydroxy or alkoxy;
ii) CH 2 C(R 6 R 7 )CH 2 , where R 6 and R 7 are each independently alkyl, perfluoroalkyl, aryl, or fluoro, or R 6 and R 7 are connected together to form a carbocyclic or heterocyclic ring;
iii) CH 2 OCH 2 , CH 2 C(O)CH 2 , or CH 2 CH 2 ; and
iv) a carbocyclic, heterocyclic, aryl or heteroaryl ring; and
R 8 and R 9 are independently selected from hydrogen, alkyl, perfluoroalkyl, alkoxy, aryl and heteroaryl, or R 8 and R 9 are connected together to form a carbocyclic or heterocyclic ring.
10. The method of claim 9 , wherein R a and R b are independently selected from hydrogen, acyl, alkoxyacyl and aminoacyl.
11. The method of claim 9 , wherein the compound has a structure of general formula 44,
12. The method of claim 11 , wherein R a and R b are independently selected from hydrogen, acyl, alkoxyacyl and aminoacyl.
13. The method of claim 11 for ameliorating or treating a disease or condition associated with inflammation.
14. The method of claim 11 , wherein the compound has a structure of general formula 29,
15. The method of claim 14 , wherein R a and R b are independently selected from hydrogen, acyl, alkoxyacyl and aminoacyl.
16. The method of claim 14 for ameliorating or treating a disease or condition associated with inflammation.
17. A method of ameliorating or treating a disease or condition associated with inflammation, autoimmune disease, or rheumatoid arthritis, the method comprising administering to a subject an effective amount of a compound having a structure of general formula 25:
wherein:
R a and R b are independently selected from hydrogen, alkyl, aryl, heteroaryl, acyl, silyl, alkoxyacyl and aminoacyl; R 1 and R 2 are independently selected from hydrogen, alkyl, perfluoroalkyl, aryl and heteroaryl;
Q is selected from the group consisting of: ——C(O)-A, ——SO 2 -A, ——PO(OR)-A, where A is hydroxyl, alkoxy, aryloxy, amino, alkylamino, dialkylamino, or ——OM, where M is a cation selected from the group consisting of ammonium, tetra-alkyl ammonium, Na, K, Mg, and Zn, and R is hydroxyl or alkoxy; and
Y and Z are linkers independently selected from a ring containing up to 20 atoms and a chain of up to 20 atoms, provided that Y, Z and W can independently include one or more nitrogen, oxygen, sulfur or phosphorous atoms, and further provided that Y, Z and W can independently include one or more substituents selected from hydrogen, alkyl, alkenyl, alkynyl, aryl, heteroaryl, chloro, iodo, bromo, fluoro, hydroxyl, alkoxy, aryloxy, carboxy, amino, alkylamino, dialkylamino, acylamino, carboxamido, cyano, oxo, thio, alkylthio, arylthio, acylthio, alkylsulfonate, arylsulfonate, phosphoryl, and sulfonyl, and further provided that Y, Z and W can also contain one or more fused carbocyclic, heterocyclic, aryl or heteroaryl rings, and provided that all linkers Y are connected to the adjacent C(R)OR group via a carbon atom.
18. The method of claim 17 , wherein R a and R b are independently selected from hydrogen, acyl, alkoxyacyl and aminoacyl.
19. The method of claim 17 , for ameliorating or treating a disease or condition associated with inflammation.
20. The method of claim 17 , wherein Y is propylene and Z is methylene.
21. The method of claim 20 , wherein R a and R b are independently selected from hydrogen, acyl, alkoxyacyl and aminoacyl.
22. The method of claim 20 , for ameliorating or treating a disease or condition associated with inflammation.